FedEx Corp. has managed to fall out of a basement window. Expectations heading into the parcel-delivery company’s fiscal fourth-quarter earnings were low. In the past six months, the company cut its 2019 outlook twice amid a weakening global trade backdrop; announced a series of puzzling executive departures; became a candidate for inclusion on China’s list of unreliable entities; and dropped ...

When the maker of the top-selling arthritis drug says it’s buying a leader in anti-wrinkle treatments, you’d be forgiven if your initial response to the news was that it seems like a match made in heaven. But take a closer look, and AbbVie Inc.’s $63 billion purchase of Botox maker Allergan Plc isn’t such a perfect fit. AbbVie is desperate ...

President Donald Trump’s decision to restart sales of US technology products to Huawei Technologies Co. may ease tensions with China, and even help end the trade war. Yet as far as deals go, this is set to be one of Trump’s worst. It doesn’t stop the technology cold war underway, and weakens the US stance that Huawei isn’t just a ...